Komentarai Siųsti draugui Spausdinti Vertinimas Neįvertintas

GRD: JSC „Grindeks” considers options of manufacturing expansion

Spekuliantai.lt | 2009-06-05 | NASDAQ OMX biržų naujienos | perskaitė: 1489
Raktiniai žodžiai: Grindeks, GRD
GRD: JSC „Grindeks” considers options of manufacturing expansion

Grindeks Company Announcement 05.06.2009

JSC „Grindeks” considers options of manufacturing expansion

JSC „Grindeks” informs on business analysis regarding manufacturing expansion
and establishment of injection plant. The purchase of the injections
manufacturing company is another option for expansion that is still on the
agenda. Any decisions regarding establishment or purchase of the injection
plant are not taken yet. At the moment injections are produced under the
contract manufacturing agreements in pharmaceutical companies in Lithuania,
Poland and Slovakia.

„Grindeks” believes that it will keep the current growth dynamics in existing
and new markets and finish the year 2009 successfully with up to 78 million
lats turnover.

„Grindeks” works actively to complete the registration process of the brand
product Mildronate® in China until the end of 2009. The positive result will
depend on decisions of China State Food and Drug Administration agency whether
to carry out additional research of Mildronate® technology.

About “Grindeks”

“Grindeks” is the leading pharmaceutical company in the Baltic States. The main
directions of its operation are research, development, manufacturing and sales
of original products, as well as generics and active pharmaceutical
ingredients. “Grindeks” specializes in the heart and cardiovascular,
psychotropic and anti-cancer therapeutic groups of medications.

„Grindeks” concern consists of four subsidiary companies in Latvia, Estonia and
Russia; as well as representatives and representative offices in 14 countries.
Products of the company are exported to more than 40 countries and its export
comprises more than 96% of the total turnover. The main markets are the Baltic
States, Russia and other CIS countries, as well as Japan and USA. The shares of
JSC „Grindeks” are listed in the Official List of „NASDAQ OMX Riga”.

Further information:
Laila Kļaviņa
Head of the Communications Department JSC “Grindeks”
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
E-mail: laila.klavina@grindeks.lv

Taip pat skaitykite

DPK: Decisions of the regular meeting of shareholders dated 27.05.2013


VLN: The results of the primary placement auction of Lithuanian Government securities

VLN: VVP pirminio platinimo aukciono rezultatai

2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos


Ekonominis kalendorius

Prekybos statistika realiu laiku

Techninės analizės įrankis


Privatumo politika Reklama Kontaktai Paskolos RSS RSS
© 2006-2022 UAB All Media Digital